Dr. Tianyi Tang, MD, PhD

Dr. Tang practices at Concord Medical Center in Concord, California, part of John Muir Health.

Dr. Tang's NPI, 1902285760, was assigned on May 27, 2015. Dr. Tang graduated from Sun Yat-Sen University of Medical Science in 2006. Dr. Tang holds California license A151192.

Dr. Tang's primary practice is Concord Medical Center, at 2540 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 682-8200.

Dr. Tang's primary practice is Concord Medical Center in Concord, California, part of John Muir Health. Dr. Tang is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Medical Group. Dmand AI also links Dr. Tang to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tang practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tang is board certified in hematology by the American Board of Internal Medicine. Dr. Tang is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Tang treats.

CMS data shows 3,678 Medicare services from Dr. Tang across 18 procedure codes in 2024, for 575 Medicare patients. Medicare paid $207,825 for them.

CMS counts 575 Medicare patients who saw Dr. Tang in 2024. The largest group is 65 to 74, with 216 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tang's median patient age at 69, with 63% women.

In 2024, Dr. Tang wrote 721 Medicare Part D claims for 154 patients. 76% of them were for generic drugs. CMS names the drug for 482 of them, across 17 drugs with 11 or more claims each, at $224,083 in total drug cost. In 2023, CMS named 244 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Tang for performance year 2024, reported as part of a group. Dr. Tang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tang as offering telehealth.

Dmand AI links 7 papers to Dr. Tang, published from 2010 to 2016. The most frequent topics are Phosphorylation, Gene Knockout Techniques and Lipase. Dr. Tang's most frequent co-authors are Maryam Ahmadian, NP, Robert Eldabaje, MD and Marc Kopel Hellerstein, MD.

CMS Open Payments shows 311 general payments to Dr. Tang from 47 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 76% of the total. Genentech, Inc. paid the most, $2,256.

Dr. Tang graduated from Sun Yat-Sen University of Medical Science in 2006.

Dr. Tang is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.